Too few ill for Liberia Ebola vaccine trial

2015-01-26 17:47
Flu vaccine (Picture: <a href="http://www.shutterstock.com">Shutterstock</a> )

Flu vaccine (Picture: Shutterstock )

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Davos - A steep fall in Ebola cases in Liberia will make it hard to prove whether experimental vaccines work in a major clinical trial about to start in the country, the head of the US National Institutes of Health (NIH) said on Saturday.

The NIH might have to move some testing to neighbouring Sierra Leone, while regulators could end up approving Ebola shots based on efficacy data from animal tests backed by only limited human evidence, Francis Collins told Reuters.

Liberia, once the epicentre of West Africa's deadly Ebola epidemic, has just five remaining confirmed cases of the disease, a senior health official has said.

The sharp decrease in cases is clearly good news, but it poses a problem for scientists from the NIH, GlaxoSmithKline and Merck, who want to enrol 27 000 people at risk of infection in the pivotal Phase III Liberian study.

"It's going to be a hard trial," Collins said on the sidelines of the World Economic Forum in Davos. "It's possible we may have to move some of the effort to Sierra Leone, which is unfortunately in not quite such a good position as Liberia."

The big Liberian trial, the first of several planned for West Africa, aims to enroll at-risk people such as healthcare staff, family members and burial workers. It will test a GSK vaccine, a rival one from Merck and NewLink, and a placebo.

"It may, at this point, be hard to find 27 000 people at risk," Collins said. "It is going to be challenging."

Nonetheless, vaccines could still be submitted to regulators using efficacy data from non-human primate experiments, plus proof of safety and immune system response in humans.

"That is the default and certainly the FDA [US Food and Drug Administration] has that particular pathway available. If it is not possible to get the rigorous human data, it is still possible a vaccine could be approved," Collins said.

Healthcare experts meeting in Davos this week have stressed the need to keep up the fight against Ebola until there are zero cases in West Africa, where more than 8 600 people have died from the disease.

Jeremy Farrar, director of Britain's Wellcome Trust health charity, said vaccines and drugs were still needed for the current epidemic and to fight future ones.

Johnson & Johnson, working with Bavarian Nordic , also has an Ebola vaccine in earlier-stage clinical tests.

Read more on:    fda  |  liberia  |  switzerland  |  west africa  |  ebola

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Comments have been closed for this article.

Inside News24

 
/News

Book flights

Compare, Book, Fly

Traffic Alerts
Traffic
There are new stories on the homepage. Click here to see them.
 
English
Afrikaans
isiZulu

Hello 

Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.


Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Settings

Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.




Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.